drugset / Trial / NCT02380976

Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers

NCT02380976 ↗

Phase 1 Completed 24 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single-dose, crossover Phase I Study to investigate the relative bioavailability of DW340 and DW330SR + DW1030 co-administration in healthy male volunteers.

Timeline

Start
2015-10
Primary completion
2015-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DW1030 Unknown — —
Subject DW330SR Unknown — —
Subject DW340 Unknown — —

Indications

No indication recorded.